What Adherence Cartography does

Adherence Cartography is a privately held digital health company headquartered in Long Beach, California, founded in 2025 by Philip Morisky (eldest son of MMAS inventor Dr. Donald E. Morisky). The company operates ATLAS (Adherence Tracking & Longitudinal Assessment System), a cloud-based research and clinical platform built on Firebase RTDB with AWS Lambda authentication, deployed across 90+ countries. ATLAS deploys three validated adherence instruments — MAP (an independently authored 8-item behavioral instrument), PEACS v2.0 (a 22-item composite producing five adherence phenotypes), and MMAS-8 (legacy gold-standard scale licensed from MMAR LLC) — all scored under the Theory of Predictive Emergence (TPE), a published mathematical framework (PE = (A × E × Cg)^⅓, CC BY 4.0, DOI: 10.5281/zenodo.18209699) that models adherence as a non-compensatory multiplicative construct.

ATLAS serves three distinct user segments via tiered SaaS subscriptions: students (Student $19/mo, Researcher $49/mo, PI Multi-Site $149/mo), institutions (Academic $399/mo, Health System $599/mo, Academic Medical Center $799/mo), and partners via REST API (Research $8K/yr, Professional $18K/yr, Enterprise custom). Ancillary revenue streams include the Global Adherence Index (population-level HEOR intelligence), TESSERA GRC consortium memberships ($3K-$15K+/year), the one-time Student Publication License ($49-$249), the Codex presale, and the ΞXPERT certification program. The company monetizes both productized self-serve tiers and direct enterprise sales, supplemented by community-led growth through the TESSERA consortium and API-first distribution via the Partner Portal.

Go-to-market combines product-led growth (automated workspace key issuance at keys.adherence.cc), direct enterprise sales (demo requests for Health System/AMC tiers), API-first distribution (three-tier Partner API for EHR and digital health integrations), and community-led expansion through TESSERA GRC and the annual World Adherence Day observance. The platform maintains HIPAA BAA with AWS and full 21 CFR Part 11 compliance, positioning it for FDA-regulated studies and clinical trial endpoint deployment. The customer base spans 49 partner institutions including top-tier pharma (Novartis, Pfizer, AstraZeneca, AbbVie, Janssen), academic medical centers (Johns Hopkins, Sapienza, Peking Union, Ludwig Maximilian, Makerere), and government health ministries (Bhutan), with named live assessments totaling 4,100+ as of the most recent disclosure.

Name

Adherence Cartography

Legal name

Adherence Inc.

Website

https://adherence.cc

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Adherence Cartography operates ATLAS, a cloud-based platform deploying the MAP adherence instrument and Theory of Predictive Emergence across 90+ countries. It serves students, researchers, clinicians, and pharma via tiered SaaS, a REST API for EHR integration, and the TESSERA global research consortium.

Ownership category

akta.pro rank

Headquarters

HQ city

Long Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. ATLAS Platform Subscriptions: Tiered SaaS subscriptions for workspace access to ATLAS platform, MAP instruments, and PEACS scoring. Includes Student ($19/mo), Clinician/Researcher ($49/mo), PI Multi-Site ($149/mo), Academic ($399/mo), Health System ($599/mo), and AMC ($799/mo) tiers. Billed monthly or annually with annual discounts of $29-$1,598. BAA and DUA included at Health System and AMC tiers.
2. Student Publication License: One-time flat-rate payment for students whose data collection is complete: $49 (10-50 participants), $89 (51-200), $149 (201-500), $249 (500+). Issues permanent PUB-XXXX-XXXX-XXXX key and Letter of Permission PDF instantly.
3. Partner API Access: Annual subscription-based API access for hospital, clinical app, and research platform integrations. Tier 1 Research at $8,000/year (up to 10,000 submissions), Tier 2 Professional at $18,000/year (up to 50,000 submissions), Tier 3 Enterprise with custom pricing, unlimited submissions, and dedicated onboarding engineer.
4. Global Adherence Index (GAI): Population-level de-identified adherence intelligence product for HEOR teams, health ministries, and pharma medical affairs. Quarterly PDF snapshot and Annual comprehensive report available; Enterprise tier offers real-time API access with JSON output, BAA/DUA available.
5. Patient Portal Access: No separate charge; patient portal access is included with all ATLAS workspace tiers. Patients access results via PIN and patient number login without requiring a subscription.
6. TESSERA Consortium Membership: Annual membership fees for the global research consortium: Institutional Partner from $3,000/year, Research Affiliate (subsidized), Student Affiliate (no cost), Validation Partner (no cost), Industry Partner from $15,000/year. Provides scientific recognition, grant resources, co-authorship network, and consortium governance.
7. Codex Presale: The Codex of Cartographic Behavioral Science — six-book manuscript by Philip Morisky — available via interest list for presale. Revenue from book sales through Adherence Inc. Press.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels11 records

Core offering

Adherence Cartography sells the ATLAS (Adherence Tracking & Longitudinal Assessment System) cloud platform, a global adherence intelligence layer that measures medication adherence using the proprietary MAP instrument, scores it under the Theory of Predictive Emergence mathematical framework, and deploys the result across students, academic researchers, clinicians, health systems, and pharmaceutical sponsors in 90+ countries. The company also sells a Partner REST API, Global Adherence Index population intelligence reports, TESSERA consortium memberships, a Student Publication License, ΞXPERT certification training, and a six-book publication (The Codex) — all anchored on the same MAP/PEACS/MMAS-8 measurement instruments.

Product overview

Adherence Cartography operates as a platform-plus-modules architecture anchored by ATLAS (Adherence Tracking and Longitudinal Assessment System), a cloud-based research and clinical platform for medication adherence measurement, prediction, and action. ATLAS serves three distinct audiences—students (IRB-ready thesis workspace at $19/month), researchers (multi-site RCT infrastructure at $49/month), and clinicians (Sentinel triage with MTM billing at $499/year)—deploying three validated instruments: MAP (Multidimensional Adherence Parameters, the primary 8-item instrument), PEACS v2.0 (Predictive Emergence Assessment for Clinical Services, 22-item composite producing five phenotypes), and MMAS-8 (legacy gold-standard scale for method comparison). Core instruments are powered by the Theory of Predictive Emergence mathematical framework (PE = cube root of Architecture × Execution × Context-Guard) enabling predictive behavioral scoring unavailable in additive models. Supporting modules include the Patient Portal (Grade 6 plain-language result viewing), Developer API (7-endpoint REST API at partner-api.adherence.cc for embedding adherence science into external platforms), Global Adherence Index (de-identified population-level HEOR intelligence in Quarterly, Annual, and Enterprise API tiers), Student Publication License (one-time $49-$249 key for completed thesis data), TESSERA Global Science Fellowship (sponsored LMIC researcher access), ΞXPERT Certification (CME/ECM-accredited training), and The Codex (six-book behavioral science publication by Philip Morisky). The TESSERA GRC consortium connects 49 partner institutions across universities, health systems, pharma, and government agencies through shared MAP deployment. All products operate under the Adherence Cartography brand in Long Beach, California.

Differentiator

Problem solved

Functional benefit

Brands

• ATLAS Platform: Research and clinical platform for measuring, predicting, and acting on medication adherence across 90+ countries
• ATLAS Pulse Sentinel
• PEACS v2.0
• MAP (Multidimensional Adherence Parameters)
• TESSERA GRC
• The Codex of Cartographic Behavioral Science
• ΞXPERT Certification
• ZOE AI Voice Agent
• Global Adherence Index (GAI)

Products and services

• ATLAS Platform (Adherence Tracking & Longitudinal Assessment System) Core cloud-based SaaS platform that measures, predicts, and acts on medication adherence using MAP, PEACS, and MMAS-8 instruments. Serves students running thesis studies, researchers conducting IRB trials, and clinicians managing patient populations. Tiered subscriptions from Student ($19/mo) to AMC ($799/mo), with the same instruments deployed across all tiers.
• Developer API / Partner API REST API with 7 endpoints for embedding MAP, MMAS-8, and PEACS adherence measurement into external hospital systems, clinical apps, and research platforms. Returns PE-aligned domain scores, phenotype classifications, and intervention recommendations. HMAC-signed delivery over TLS 1.3; webhook push delivery on Professional tier. Tier 1 Research ($8,000/yr, 10K submissions), Tier 2 Professional ($18,000/yr, 50K submissions), Tier 3 Enterprise (custom, unlimited).
• Student Publication License Standalone publication license for students whose thesis or dissertation data collection is complete. One-time flat-rate pricing ($49-$249 by participant count: 10-50 $49, 51-200 $89, 201-500 $149, 500+ $249). Issues permanent PUB-XXXX-XXXX-XXXX key and Letter of Permission PDF instantly. Journal and IRB verification at keys.adherence.cc/verify.
• Global Adherence Index (GAI) De-identified, population-level intelligence product derived from ATLAS submissions, aggregating adherence data by disease state, country, adherence tier, and time period. Three tiers: GAI Quarterly (PDF snapshot, four reports/year), GAI Annual (full-year synthesis with all quarterly data plus analyst briefing), GAI Enterprise (real-time API access with configurable filters, JSON output, BAA/DUA available). For HEOR teams, HTA bodies, health ministries, and pharma medical affairs.
• TESSERA GRC Global Research Consortium Global research consortium connecting researchers, clinicians, and institutions through shared MAP instrument deployment and access to the normative dataset. Five membership tiers: Institutional Partner ($3,000+/year), Validation Partner (free), Research Affiliate (subsidized), Student Affiliate (free), Industry Partner ($15,000+/year). Members gain co-authorship pathways, grant resources, validation coordination, and access to global MAP normative database across 150+ countries.
• TESSERA Global Science Fellowship Sponsored 12-month Researcher-tier ATLAS access for qualifying low- and middle-income country researchers with validated study protocol and institutional ethics approval. Fellows receive MAP instruments, full ATLAS platform access, co-authorship invitation on annual TESSERA global report, and Tier 3 consortium membership. Requires minimum 50 patient assessments/year and anonymized aggregate data contribution.
• ΞXPERT Certification Training and certification program for healthcare professionals on adherence science methodology, MAP administration, and Theory of Predictive Emergence application. ΞXPERT credential awarded to qualifying clinicians and pharmacists. CME/ECM-accredited training programs available, including the Italian ECM Symposium delivered January 2026 in partnership with SIMAT.
• The Codex of Cartographic Behavioral Science Six-book publication by Philip Morisky extending the Theory of Predictive Emergence as a universal framework for behavioral forecasting across domains including medication adherence, mental health, education, organizational performance, criminal justice, and financial stability. Books cover Foundations of Predictive Emergence, Mental Health Cartography, The Universal Terrain, Measurement and Methodology, Philosophical Horizons, and The Horizon of Unknowing. Published by Adherence Inc. Press; presale interest list active.

Quantifiable outcome

• PE retrospective validation r = +0.787
• +4 more outcomes

Named customers11 records

Segments8 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature7 records

Partnerships

29 partnerships are on record, tiered core and minor.

• SIMAT (Società Italiana di Medicina e Assistenza Territoriale)coreStrategic or Co-development Partner · 27 March 2026Italian scientific society partner for medication and territorial assistance. Partnership includes Italian Senate address by Philip Morisky on World Adherence Day 2026, ECM-accredited MAP and TPE training program delivery to Italian clinicians, and collaborative international observance activities.
• Ministry of Health BhutancoreStrategic or Co-development Partner · 27 March 2026Government health ministry partner and TESSERA Institutional Partner. Participated in World Adherence Day 2026 global observance, representing national-level government commitment to medication adherence science.
• World Adherence Day (Global Partner Network)coreStrategic or Co-development Partner · 27 March 2026Annual international observance of medication adherence held March 27, 2026. Partner institutions including Ministry of Health Bhutan, University of Nicosia, Al Thiqa Pharmacy UAE, NUST Oman, and SAPLIA University participated in coordinated global adherence science activities. Philip Morisky addressed the Italian Senate as part of the observance.
• ALAT Colombia (Asociación Latinoamericana de Tórax)coreStrategic or Co-development PartnerMedical society partner and TESSERA Institutional Partner in Latin America. Represents respiratory and thoracic medicine adherence research network.
• HapREDco ColombiaminorStrategic or Co-development PartnerHealth research organization and TESSERA Institutional Partner in Colombia focused on health research and development.
• InHandPlus KoreacoreTechnology or IntegrationAI wearable technology partner. InHandPlus and Adherence Cartography partner to launch digitized PEACS integration combining AI Smart Watch analytics with patient-reported PEACS data for comprehensive adherence monitoring.
• Sempli Farma (Italy)minorChannel Partner/ Reseller/ DistributorPharmacy technology partner in Italy for MAP instrument deployment through pharmacy networks.
• Al Thiqa Pharmacy (UAE)minorChannel Partner/ Reseller/ DistributorUAE pharmacy network partner. Participated in World Adherence Day 2026 global observance.
• NovartiscoreOthersNovartis has used MMAS-8 as a validated adherence endpoint in multiple peer-reviewed clinical trials (NCT00394823, NCT01709812, NCT02335892, NCT05734053, NCT06431763, NCT06958315). MAP is now available as the next-generation instrument for Novartis trial protocols.
• PfizercoreOthersPfizer has used MMAS-8 as a validated adherence endpoint in multiple peer-reviewed clinical trials (NCT00343200, NCT00709787, NCT01293825, NCT01388166, NCT02187042, NCT03718117). MAP availability positions Pfizer to adopt the next-generation PE-scored instrument for higher-resolution adherence endpoints.
• AstraZenecacoreOthersAstraZeneca has used MMAS-8 as a validated adherence endpoint across the largest number of clinical trials among listed pharma partners (NCT00681759, NCT00769080, NCT00873249, NCT00927420, NCT01176682, NCT01577563, NCT02749435, NCT02805283, NCT03090464, NCT06327815).
• AbbViecoreOthersAbbVie has used MMAS-8 as a validated adherence endpoint in peer-reviewed clinical trials (NCT01768858, NCT02750800, NCT04080856).
• JanssencoreOthersJanssen has used MMAS-8 as a validated adherence endpoint in peer-reviewed clinical trials (NCT02262676, NCT02610153, NCT02996435).
• Sapienza University of RomecoreStrategic or Co-development PartnerLeading European university partner in the TESSERA GRC network. Represents one of the most prominent academic medical research institutions globally deploying MAP through ATLAS.
• University of the Philippines ManilacoreStrategic or Co-development PartnerLeading Southeast Asian university partner in the TESSERA GRC network with active MAP deployment and validation studies.
• University of Nicosia (Cyprus)coreStrategic or Co-development PartnerUniversity partner and home of advisory board member Dr. Aliki Peletidi. Active in the TESSERA GRC network, participated in World Adherence Day 2026, and coordinates MPharm program integration with ATLAS.
• NUST OmancoreStrategic or Co-development PartnerNational University of Science and Technology Oman partner in TESSERA GRC. STRATA scale underwent specific validation revision for Gulf populations at this institution. Participated in World Adherence Day 2026.
• Cyprus University of TechnologycoreStrategic or Co-development PartnerEuropean TESSERA GRC partner university in Cyprus conducting active adherence research and MAP validation studies.
• Johns Hopkins Bloomberg School of Public Health (USA)coreStrategic or Co-development PartnerElite US academic public health institution partner listed among the global research network, using MMAS-based adherence measurement in public health research programs.
• Ludwig Maximilian University Munich (Germany)coreStrategic or Co-development PartnerElite European university partner in the ATLAS research network, contributing to the global adherence science commons.
• Peking Union Medical College Hospital (China)coreStrategic or Co-development PartnerPremier Chinese academic medical center partner in the ATLAS research network, representing Asian population adherence data contributions.
• Vietnam National University HanoiminorStrategic or Co-development PartnerVietnamese university partner in the ATLAS research network contributing Southeast Asian adherence data.
• University of Sao Paulo (Brazil)coreStrategic or Co-development PartnerLeading South American university partner in the TESSERA GRC network, representing Brazilian and Latin American adherence science research.
• Makerere University College of Health Sciences (Uganda)coreStrategic or Co-development PartnerLeading African university partner contributing to the TESSERA GRC network's coverage of sub-Saharan African populations.
• University of Lagos Teaching Hospital (Nigeria)coreStrategic or Co-development PartnerWest African hospital partner in the ATLAS research network representing Nigerian and broader West African adherence research populations.
• King Abdulaziz Medical City (Saudi Arabia)coreStrategic or Co-development PartnerLeading Saudi Arabian academic medical center partner in the ATLAS research network for Middle East population adherence data.
• Hamad Medical Corporation (Qatar)coreStrategic or Co-development PartnerQatar's national healthcare provider and research partner in the ATLAS network for Gulf region adherence science.
• Jordan University of Science and TechnologycoreStrategic or Co-development PartnerJordanian university partner in the ATLAS research network contributing to Middle East and Arab world adherence data.
• University of Sydney (Australia)coreStrategic or Co-development PartnerAustralian university partner in the ATLAS research network representing Oceania and Western Pacific adherence research.

Scale indicators12 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• AiCure: AI-powered medication adherence platform using computer vision to confirm patient dose ingestion. Directly comparable as a validated adherence measurement and trial endpoint provider serving pharma sponsors with similar clinical research use cases.
• Wellth: Behavioral economics-driven medication adherence platform using financial incentives and daily check-ins. Comparable as a digital adherence intervention serving health plans and providers with measured outcomes.
• Medisafe: Consumer-facing digital medication adherence platform with 10M+ users, offering reminders, tracking, and family/caregiver support. Comparable as a patient engagement and adherence measurement platform with similar patient-facing portal functionality.
• emocha Health: Video DOT (Directly Observed Therapy) adherence platform acquired by Maven, serving public health agencies and providers. Comparable as a digital medication adherence measurement platform with health system and government customers.
• AdhereTech: Smart pill bottle platform that measures adherence through connected device sensors and transmits data to care teams. Comparable as a connected medication adherence measurement technology with pharma and provider customers.
• MedMinder: Smart medication dispenser and adherence monitoring platform for patients and providers. Comparable as a connected medication adherence and packaging solution serving pharmacy, provider, and patient markets.
• Castor EDC: Cloud-based clinical research platform for capturing and managing trial data with API integrations. Comparable as a SaaS platform serving academic and commercial researchers with IRB-grade data capture and study management.

Emerging players

• Observia: French digital health company developing patient engagement and adherence solutions. Both partner and peer in the TESSERA GRC consortium network, with comparable patient adherence technology focus.

Broad incumbents

• Propeller Health (ResMed): Digital respiratory medication adherence platform (acquired by ResMed) using sensor-connected inhalers for asthma and COPD. Comparable as an established digital therapeutic adherence platform serving pharma and payers at scale.
• REDCap: Free, widely-deployed academic clinical research data capture platform used by 6,000+ institutions. Comparable as the incumbent academic research data platform that ATLAS PI Multi-Site tier explicitly positions against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/philip-morisky
• Facebookfacebook.com/profile.php

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adherence Cartography